Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (NCT05076942)

🧪 Interventions in This Study

• Cisplatin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (27 Sites)

Showing the first 25 of 27 sites.

• UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
• Mount Sinai Medical Center — Miami Beach, Florida
• Baystate Medical Center — Springfield, Massachusetts
• Spectrum Health at Butterworth Campus — Grand Rapids, Michigan
• Munson Medical Center — Traverse City, Michigan
• Nebraska Methodist Hospital — Omaha, Nebraska
• Women's Cancer Center of Nevada — Las Vegas, Nevada
• Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
• Memorial Sloan Kettering Monmouth — Middletown, New Jersey
• Memorial Sloan Kettering Bergen — Montvale, New Jersey
• Memorial Sloan Kettering Commack — Commack, New York
• Memorial Sloan Kettering Westchester — Harrison, New York
• Memorial Sloan Kettering Cancer Center — New York, New York
• Memorial Sloan Kettering Nassau — Uniondale, New York
• Duke University Medical Center — Durham, North Carolina
• Duke Women's Cancer Care Raleigh — Raleigh, North Carolina
• Ohio State University Comprehensive Cancer Center — Columbus, Ohio
• ProMedica Flower Hospital — Sylvania, Ohio
• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
• Women and Infants Hospital — Providence, Rhode Island
• Avera Cancer Institute — Sioux Falls, South Dakota
• Catharina Hospital Eindhoven — Eindhoven,
• University Medical Center Groningen — Groningen,
• Leiden University Medical Center — Leiden,
• Radboud University Medical Center — Nijmegen,

📞 Contact the Study Coordinator

Phone: +31-50-3613000

Email: m.h.m.oonk@umcg.nl

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Vulvar Cancer

• Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer — Basking Ridge, New Jersey
• Cisplatin+Pembrolizumab+RT in Vulvar Cancer — Boston, Massachusetts
• Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. — Toronto, Ontario
• STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision — Vancouver, British Columbia
• Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma — Hamilton, Ontario

Explore by condition: All Vulvar Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.